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Abstract: Mycoplasma equirhinis and Mycoplasma felis are thought to be infectious etiologic agents of inflammatory airway disease
(IAD), which, after musculoskeletal injuries, is the second most common cause of poor performance in thoroughbred racehorses. The
aims of this study were to investigate for the first time the presence of M. equirhinis, M. felis, and other Mycoplasma spp. in the lower
respiratory tract of racehorses in İstanbul Province in Turkey and to statistically evaluate the association between clinical signs of IAD
and the presence of mycoplasmas. Tracheal wash (TW) samples were collected from 111 English and Arabian thoroughbred horses that
showed clinical signs of IAD. TW samples were examined by culture and PCR methods. The detection rates of Mycoplasma spp., M.
felis, and M. equirhinis were found to be 16.2%, 0%, and 18% by culture and 59.5%, 1.8%, and 6.3% by PCR in TW samples, respectively.
According to statistical evaluations, a significant association was found for the presence of M. felis in English thoroughbred racehorses.
However, no significant association was found between clinical signs of IAD and the presence of M. equirhinis, M. felis, and other
Mycoplasma spp.
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1. Introduction
Besides musculoskeletal injuries, diseases of the airway in
thoroughbred racehorses are the second most frequently
encountered disorders (1), and inflammatory airway
disease (IAD) is one of the most common of these diseases
in racehorses (2,3). Poor performance, increased amounts
of mucus in the trachea, coughing, and nasal discharge are
all clinical signs associated with IAD (2). Horses of any
age can be affected, but IAD is more commonly reported
in younger horses (2). A variety of etiological agents
may be involved in IAD, and their relative contribution
in the development of the disease varies within different
populations according to many factors such as the genetic
makeup of the animal and the type of infectious agent but
also environmental conditions, feeding, housing season,
and preventive medicine practices. Beta-hemolytic
streptococci, Actinobacillus/Pasteurella spp., Klebsiella
pneumoniae, Bordetella bronchiseptica, and Streptococcus
pneumoniae are isolated from IAD cases as bacterial
pathogens (1,4,5). In addition to these agents, Mycoplasma
equirhinis and Mycoplasma felis can also be isolated from
the lower respiratory tract of horses and are determined to
be the etiologic agents of IAD (1,3,4,6–8).
* Correspondence: alpermete1985@yahoo.com

Mycoplasma species are small prokaryotes that do not
synthesize peptidoglycan and therefore lack cell walls.
Many Mycoplasma species are the causative agents of
significant diseases such as pneumonia, pleuritis, arthritis,
urogenital infections, and mastitis in humans, ruminants,
pigs, poultry, and horses (9,10).
Previous studies in different populations have showed
that the presence of Mycoplasma spp. was determined
to be 9.5% (11), 3% (12), and 10% (13), while the
presence of M. equirhinis was determined to be 12.3%
(3), 10.2% (4), 14% (7), and 10.4% (14) in tracheal wash
(TW) samples by culture. The presence of M. felis was
determined as 1.4% (3), 1.4% (4), 8% (7), and 1.35%
(14) by culture. Unfortunately, no previous studies could
be found to detect these microorganisms by PCR in
TW samples. M. felis, which was isolated from a female
hypogammaglobulinemic patient with septic arthritis,
also had zoonotic significance (15). M. equirhinis has no
significance as a zoonotic infectious agent. There have been
no previous studies showing the presence and prevalence
of Mycoplasma in the respiratory tract and its association
with signs of respiratory disease in any horses, including
thoroughbreds and non-thoroughbreds, in Turkey. The
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objectives of the present study were to investigate for the
first time the presence of Mycoplasma spp., M. equirhinis,
and M. felis in TW samples in İstanbul Province and to
evaluate the statistical association between clinical signs of
IAD and the presence of these agents.
2. Materials and methods
2.1. Samples
A total of 111 TW samples were collected from 82 (73.88%)
English and 29 (26.12%) Arabian thoroughbred horses.
The samples were submitted to the İstanbul Race Horse
Hospital along with complaints of poor performance and/
or abnormal respiratory sounds at rest or while training.
The same clinician evaluated the clinical signs of the
horses, and the amount of tracheal mucus accumulation
(classified as none, little, intermediate, or high), poor
performance, coughing at rest or during exercise, and nasal
discharge were recorded while collecting samples from the
horses (2,5,16–18). The sex, age, and strain (English or
Arabian thoroughbred) of the horses were also recorded.
TW samples were collected during the endoscopic
examination of the respiratory tract. A flushing catheter
was passed through the biopsy channel of the endoscopy,
and the carina was washed with 30 mL of sterile 0.9%
saline solution. The content was then aspirated back to
a sterile 60-mL sterile syringe (19). The specimens were
immediately sent to the laboratory and stored at –20 °C
prior to laboratory analysis.
2.2. Culture
The TW samples were subjected to Mycoplasma cultivation
as previously described (18–20). The specimens were
inoculated in a Mycoplasma broth base (Oxoid CM 0403)
and a Mycoplasma agar base (Oxoid CM 0401, Thermo
Scientific, Waltham, MA, USA) supplemented with
Mycoplasma selective supplement-G (Oxoid SR0059C,
Thermo Scientific), both of which were prepared according
to the manufacturer’s instructions. The TW samples were
inoculated into the mediums by adding 1 mL of sample to
the 9 mL of broth medium, and 1 drop (50 µL) of sample
was streaked onto the surface of the agar medium. Both the
broth and the agar mediums were inoculated at the same

time. The plates and broth cultures were incubated at 37
°C in a highly moist atmosphere containing 5% CO2. They
were checked daily for growth by evaluating the turbidity
of the broth culture and stereomicroscopic examination
of the agar culture plates. Two blind passages were made
from the broth cultures to eliminate contaminant bacterial
and fungal agents and to isolate mycoplasmas. After two
passages, the broth and agar cultures were inoculated for
an additional 14 days. If no growth was seen at the end of
the 14-day period, the sample was evaluated as negative by
culture. If growth was seen, the suspected colonies were
subcultured on a fresh broth medium. The subcultured
broth medium and Mycoplasma-suspected broth cultures
were stored at –20 °C until PCR assays were carried out for
identification.
2.3. DNA extraction
DNA was extracted from the suspected broth cultures and
from the TW samples according to the manufacturer’s
instructions using a commercial kit (Sigma GenElute
Bacterial Genomic DNA Kit, Sigma-Aldrich Life Sciences,
Darmstadt, Germany).
2.4. PCR
Three types of PCR were used in the study (Table 1).
Mycoplasma spp. PCR was performed to detect Mycoplasma
spp. in the TW samples and for genus-specific identification
of the isolated colonies (21). The PCR reaction mix of
25 µL included 0.5 µL of each primer (10 µM), 0.5 µL of
dNTP mix (10 mM), 2.5 µL of 10X PCR buffer, 1.5 µL of
MgCl2 (50 mM), 0.2 µL of Platinum Taq Polymerase (5
U/µL), and 5 µL of clinical sample. PCR conditions were
as follows: initial denaturation at 94 °C for 5 min and 35
cycles of denaturation at 95 °C for 60 s, annealing at 55
°C for 60 s, and extension at 72 °C for 60 s. M. felis PCR
was performed to detect M. felis in the TW samples and to
identify the isolated colonies (22). The PCR reaction mix
of 25 µL included 0.25 µL of each primer (10 µM), 0.5 µL
of dNTP mix (10 mM), 2.5 µL of 10X PCR buffer, 0.75 µL
of MgCl2 (50 mM), 0.5 µL of Platinum Taq Polymerase (5
U/µL), and 5 µL of clinical sample. PCR conditions were
as follows: initial denaturation at 94 °C for 5 min and 35
cycles of denaturation at 94 °C for 30 s, annealing at 51.6

Table 1. Target genes, amplicon sizes, and oligonucleotide sequences used during PCR analysis.
Agent

Target gene

Amplicon size

Oligonucleotide sequence

Reference

M. equirhinis

16s rRNA

211 bp

5’-CAC CGC CCG TCA CAC CA-3’
5’-GAT CTC TCA AAA CTG AAT ACG-3’

Robinson (14)

M. felis

16s rRNA

238 bp

5’-CAC CGC CCG TCA CAC CA-3’
5’-GGA CTA TTA TCA AAA GCA CAT AAC-3’

Chalker et al. (22)

Mycoplasma spp.

16S rRNA

280 bp

5’-GGG AGC AAA CAG GAT TAG ATA CCC T-3’
5’-TGC ACC ATC TGT CAC TCT GTT AAC CTC-3’

Van Kuppeveld et al. (21)
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°C for 30 s, and extension at 72 °C for 20 s followed by a
final extension at 72 °C for 5 min. M. equirhinis PCR was
performed to detect M. equirhinis in the TW samples and to
identify the isolated colonies (14). The PCR reaction mix of
50 µL included 0.5 µL of each primer (10 µM), 1 µL of dNTP
mix (10 mM), 5 µL of 10X PCR buffer, 1.5 µL of MgCl2 (50
mM), 0.5 µL of Platinum Taq Polymerase (5 U/µL), and 10
µL of clinical sample. PCR conditions were as follows: initial
denaturation at 94 °C for 5 min and 35 cycles of denaturation
at 94 °C for 30 s, annealing at 46 °C for 30 s, and extension
at 72 °C for 20 s followed by a final extension at 72 °C for
5 min. All PCR products were analyzed using 1% agarose
gel electrophoresis with ethidium bromide staining. The
samples were accepted as positive if 280-bp, 238-bp, and
211-bp bands were seen in the agarose gel electrophoresis,
respectively. Reference culture DNAs (NCTC 10160, NCTC
10160, and NCTC 10148, respectively) as the positive
control and nuclease-free water as the negative control were
used in every PCR cycle.

2.5. Statistical analysis
The statistical analysis of the association between clinical
signs and the presence of Mycoplasma spp., M. felis, and
M. equirhinis in the TW samples was evaluated using
Pearson’s chi-square (χ2) test with SPSS (23).
3. Results
3.1. Culture
Mycoplasma-suspected colonies were isolated in 18
(16.2%) of the 111 TW samples (Figure 1). In 33 (29.7%)
specimens, bacterial and fungal contaminants were
detected in the first inoculation. All contaminants were
eliminated using a 0.45-µm syringe filter during the first
passage.
3.2. Mycoplasma spp.-specific PCR
Sixty-six (59.5%) of the 111 TW samples were positive
by Mycoplasma spp.-specific PCR. All isolated colonies
(n = 18) were also identified as Mycoplasma spp. by PCR
(Figure 2).

Figure 1. M. equirhinis colonies isolated from a tracheal wash
sample.

Figure 2. Mycoplasma spp. PCR findings in the cultures. M: Marker, 100–1000 bp, 500
ref. band; P: positive control; N: negative control; 1, 2, 8–10, 12–14: positive samples;
3–7, 11: negative samples.
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3.3. M. felis-specific PCR
Two (1.8%) of the 111 TW samples were positive by M.
felis-specific PCR (Figure 3). None of the isolated colonies
were identified as M. felis by PCR.
3.4. M. equirhinis-specific PCR
Seven (6.3%) of the 111 TW samples were M. equirhinispositive by PCR. All of the isolates (n = 18) that were
identified as Mycoplasma spp. were also M. equirhinispositive by PCR (Figure 4).
3.5. Statistical results
Statistical analysis showed that no associations were
found between clinical signs of IAD (large amounts of
mucus in the trachea, coughing, nasal discharge, and
poor performance) and the presence of Mycoplasma spp.,
M. felis, and M. equirhinis (Table 2). There was also no
association between age groups (comparing young horses
of 2–4 years old and older horses) and the presence of
Mycoplasma. There was no statistical association between
the presence of Mycoplasma spp. or M. equirhinis and
English or Arabian thoroughbred horses. However, a
statistical association between the presence of M. felis
and thoroughbred English horses was found (P < 0.05).

In addition to these results, no statistical association was
found between the presence of Mycoplasma and the sex of
the horses.
4. Discussion
Until now, no studies have shown the status of Mycoplasma
spp. in the respiratory tract of thoroughbred racehorses or
other horse groups and horse strains in Turkey; however,
there have been some studies conducted in other countries
that showed the presence of Mycoplasma in the respiratory
tract of horses. The presence of Mycoplasma spp. was found
as 10% and 9.5%, respectively, by culture in the tracheal
swabs of horses in retrospective studies (11,13). In Canada,
the prevalence of Mycoplasma was found to be 3% in TW
samples by culture (12). In the present study, the presence
of Mycoplasma spp. in the respiratory tract of horses was
found to be 16.2% by culture. Mycoplasma species are
known to be more prevalent in countries that have hot
climates with high humidity (9). This study revealed that
Mycoplasma has a high isolation rate in Turkey compared
with Canada and the United Kingdom. This high detection
rate may be due to Turkey’s hot and humid climate.

Figure 3. M. felis PCR findings in the tracheal washes. M: Marker, 100–1000 bp, 500 ref.
band; P: positive control; N: negative control; 4, 5: positive samples; 1, 2, 3, 6, 7, 8, 9, 10,
11, 12: negative samples.

Figure 4. M. equirhinis PCR findings of the Mycoplasma spp.-confirmed isolates. M:
Marker, 100–1000 bp, 500 ref. band; P: positive control; N: negative control; 1, 2, 3, 4, 5,
6, 7, 8, 9, 10, 11: positive samples; 12: negative sample.
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Table 2. Distribution of Mycoplasma detected in racehorses according to strain, age, sex, and clinical signs in Turkey.
Detected microorganism
Mycoplasma spp.

M. felis

M. equirhinis

Total number of horses
in the group

English

53 (64.6%)

2 (2.4%)

15 (18.3%)

82

Arabian

13 (44.8%)

0 (0%)

5 (17.2%)

29

2

33 (60.0%)

2 (3.6%)

11 (20.0%)

55

3

24 (66.6%)

0 (0%)

9 (25.0%)

36

4

4 (40.0%)

0 (0%)

0 (0%)

10

5

2 (50.0%)

0 (0%)

0 (0%)

4

6

2 (50.0%)

0 (0%)

0 (0%)

4

7

1 (50%)

0 (0%)

0 (0%)

2

Female

27 (57.4%)

0 (0%)

12 (25.5%)

47

Male

39 (60.9%)

2 (3.1%)

8 (12.5%)

64

Little

23 (62.1%)

0 (0%)

3 (8.1%)

37

Intermediate

26 (56.5%)

1 (2.1%)

10 (21.7%)

46

High

17 (60.7%)

1 (3.5%)

7 (25.0%)

28

Nasal discharge

16 (48.4%)

1 (3.0%)

5 (15.1%)

33

Poor performance

46 (59.7%)

0 (0%)

13 (16.9%)

77

Coughing

37 (71.2%)

2 (3.9 %)

12 (23.0%)

52

Strain information

Age, years

Sex

Amount of mucus
in trachea

No previous study has shown the presence of M.
equirhinis and M. felis, which were both thought to be
the etiologic agents of IAD in Turkey. Some studies have
revealed the presence of M. equirhinis and M. felis in other
countries. In the United Kingdom, the presence of M. felis
was found to be 1.4%, 1.4%, 8%, and 1.35%, respectively, in
different studies (3,4,7,14). The presence of M. equirhinis
was found to be 12.3%, 10.2%, 14%, and 10.4% by the same
researchers. All of the samples handled in those studies
were carried out using culture. In our study, M. felis was
not isolated from any samples; however, M. equirhinis was
isolated from 16.2% (n = 18) of the samples. These results
showed that M. equirhinis had a higher isolation rate
than M. felis, which was not isolated from TW samples in
Turkey. It was also concluded that M. equirhinis had higher
isolation rates compared with other countries.
Classification of the presence of M. equirhinis and M.
felis according to age groups revealed that M. felis was
isolated in 1.9% of 2-year-old, 1.7% of 3-year-old, and 0.7%
of 4-year-old horses. M. equirhinis was isolated in 14% of
2-year-old, 11.4% of 3-year-old, and 9.4% of 4-year-old
horses and, overall, M. felis was isolated in 1.4% of horses
of all age groups while M. equirhinis was detected in 12.3%

by culture in the United Kingdom (5). In our study, M.
felis was not isolated in any age group. M. equirhinis was
isolated from 18% in all age groups, specifically in 20%
of 2-year-old and 19.4% of 3-year-old horses. However, it
was not isolated in horses older than 3 years. These results
indicated that in all age groups the presence of M. felis was
lower in Turkey. M. equirhinis was also found to be higher
in 2- and 3-year-old horses and in all age groups.
Two M. felis-positive samples were obtained from
English thoroughbred horses, and the presence of M. felis in
English thoroughbred horses was found to be statistically
significant (P < 0.05). The presence of Mycoplasma spp.
and M. equirhinis was not associated with this horse
strain. Unfortunately, no previous studies could be found
indicating the presence of Mycoplasma species in different
horse strains.
The culture method has been used in many retrospective
studies (3–5,7,10,12,24). In our study, both culture and
PCR methods were used in order to detect M. felis and M.
equirhinis, which were thought to be associated with IAD
in horses. Mycoplasma spp. were isolated from 18 (16.2%)
culture samples while Mycoplasma spp. were detected in 66
(59.5%) PCR-positive samples taken directly from a TW.
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The detection of M. felis and M. equirhinis from TW
samples and the identification of isolates were carried out
by M. felis- and M. equirhinis-specific PCR. In this study,
we found 2 (1.8%) M. felis-positive samples by PCR but
no positive samples by culture. Within the TW samples,
all of the isolates (n = 18) were identified as M. equirhinis
by PCR. Five (27.8%) of the 18 isolates identified as M.
equirhinis were also positive by the PCR carried out
directly from the TW samples. Of the 18 samples that
were detected as M. equirhinis by culture, 13 (72.2%)
were not found positive by PCR. Two (28.6%) of the 7
TW samples found to be positive by M. equirhinis PCR
were not grown in culture. It was considered that the
empirical use of antibiotics without any recommendation
by veterinarians and high amounts of nontarget bacteria
in the TWs may have resulted in 48 Mycoplasma spp., 2 M.
felis, and 2 M. equirhinis PCR-positive but culture-negative
samples. There were also 13 M. equirhinis culture-isolated
samples that could not be detected by PCR. The inhibition
of PCR might have been due to the large number of PCR
inhibitors such as heme molecules, enzymes, proteins, and
nonspecific DNA content in the TW samples.
Unfortunately, studies could not be found that
investigated the presence of Mycoplasma by PCR in the
TW samples of horses. For this reason, we were unable to
compare our PCR results with any other previous studies.

Wood et al. (3) observed that there was a strong
association between M. equirhinis, S. zooepidemicus, S.
pneumoniae, and Actinobacillus/Pasteurella spp. and IAD.
They also indicated that mixed etiology plays a key role in
this association. The investigation of other etiologic agents
of IAD in TW samples was not performed in this study.
An investigation of the other agents in conjunction with
Mycoplasma should be carried out to better understand
the role of Mycoplasma species in IAD.
In conclusion, the detection rates of Mycoplasma spp.,
M. felis, and M. equirhinis were found to be 16.2%, 0%,
and 18% by culture and 59.5%, 18%, and 6.3% by PCR,
respectively. The presence of these agents in TW samples
could not be associated with clinical signs of IAD from
the statistical analysis. The presence of M. felis in the TW
samples of English thoroughbred racehorses was found
to be statistically significant (P < 0.05). More research,
including cytological evaluation of TW samples and
investigation of other bacteriological agents occurring
with Mycoplasma species, is needed to corroborate the
relationship between IAD and Mycoplasma.
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